No Data
No Data
Tuoxin Pharmaceutical: Report for the third quarter of 2024
Revenues Not Telling The Story For Tuoxin Pharmaceutical Group Co.,Ltd. (SZSE:301089) After Shares Rise 41%
There is a risk of diffusion! WHO has launched a global strategic preparedness, and monkeypox concept stocks have surged in response.
New variant appears.
Tuoxin Pharmaceutical Group: Half-year report for the year 2024.
Tuoxin Pharmaceutical Group: Summary of Half-Year Report in 2024.
Insiders Were the Key Beneficiaries as Tuoxin Pharmaceutical Group Co.,Ltd.'s (SZSE:301089) Market Cap Rises to CN¥4.4b
No Data
No Data